TET1 and systemic sclerosis: This study confirmed the global hypomethylation status in SSc FBs, associated with mRNA overexpression of a demethylating agent from the ten-eleven translocation family (TET), TET1, which converts 5mC to 5-hydroxymethylcytosine (5hmC) [37].